Avanir Shareholders Can't Halt Proxy Vote

Law360, Los Angeles (February 12, 2014, 9:36 PM ET) -- A California federal judge on Wednesday allowed Avanir Pharmaceuticals Inc.'s shareholder vote on issues like executive pay to proceed despite the objections of a putative class of investors claiming that its proxy notice was misleading, ruling all the information required for an informed vote was in the notice. 

U.S. District Judge Cormac J. Carney denied the plaintiffs' motion for a preliminary injunction to stop the vote, which included a proposal to issue 17 million shares to be used for equity-based compensation. Avanir had claimed it was...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required

Case Information

Case Title

Robert Masters v. Avanir Pharmaceuticals Inc. et al

Case Number

8:14-cv-00053

Court

California Central

Nature of Suit

Securities/Commodities

Judge

Cormac J. Carney

Law360 Coverage

Date Filed

January 13, 2014

Sections

Law Firms Mentioned

Companies Mentioned

Government Agencies Mentioned

Related Articles